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From the International Society for Cardiovascular Surgery
It has been an extraordinary privilege to serve as
your secretary, president-elect, and, finally, president; it
has been an opportunity that has provided me with a
unique perspective, spanning 6 years of unprecedent-
ed growth. From the original Band of Brothers, our
specialty through the joint societies has matured into a
complex, politically active team, far more capable of
representing our diverse interests in this rapidly chang-
ing environment. Exciting advances in technology
have unfortunately been tempered by draconian
reductions in health care spending, the effects of which
we have only begun to feel. I would like to briefly
emphasize some of the important areas of our soci-
eties’ growth and, in so doing, underscore a strategy
about which I’ve felt strongly for nearly two decades.
I believe that full implementation of a disease-focused
team approach that transcends the boundaries of con-
ventional disciplines will best ensure optimal cost-
effective patient care.
The Lifeline Foundation has established an effec-
tive effort designed to support our young investiga-
tors and to teach basic vascular cell and wall biology.
The Foundation has accumulated assets of more
than $3 million and has developed more appropriate
governance, representative of both industry and
academia. Our Research and Education Committee
has been folded into the Lifeline Foundation to pro-
vide appropriate expertise for critical evaluation of
grant proposals and submissions for the Research
Forum. In collaboration with the William J. Von
Liebig Foundation, the Lifeline Foundation and the
National Institutes of Health jointly sponsor two K-
08 awards each year in the amount of $150,000 for
5 years. Our young surgeon-scientists are thus
ensured an opportunity to develop the competitive
credibility for participation in independent or multi-
disciplinary basic science investigations. The Lifeline
Foundation, through its industrial representatives,
has sponsored and will provide oversight for a reg-
istry of endovascular stent-grafts to ensure impartial,
standardized reporting of long-term outcome data.
Our relationship with industry bears constant vigi-
lance, because we answer to very different masters,
but these cooperative efforts cannot help but bene-
fit our patients in the long run.
The Program Committee has been charged to
view our annual proceedings with increasing creativ-
ity, incorporating emerging technologies and a vari-
ety of postgraduate courses. The activities of the
Society for Vascular Medicine and Biology and the
Society for Vascular Technologists have been associ-
ated with our annual meeting. We have been less
successful with the Society of Cardiovascular and
Interventional Radiology and have yet to address the
interventional cardiologist in a constructive fashion.
We need to take a hard look at whether our societies
are meeting our current needs; I suspect they are
not. Through the Program Committee and our new
standing Committee for Endovascular Affairs, we
must continue to seek productive working relation-
ships with interventional radiologists and cardiolo-
gists, paralleling the multidisciplinary efforts evolv-
ing at our institutions.
In September 1996, the Joint Council’s Strategic
Planning Committee, affectionately known as the
Gang of Eight, legally constituted the American Board
of Vascular Surgery and thereby exerted the political
leverage necessary to initiate changes in the organiza-
tion of the American Board of Surgery.1 The new sub-
board infrastructure represents an ongoing feasibility
study with the potential to preserve the parent board’s
corporate oversight, yet provide functional indepen-
Presidential address: A team for the 21st
century: The vascular center
Anthony D. Whittemore, MD, Boston, Mass
From Brigham and Women’s Hospital.
Competition of interest: nil.
Presented at the Forty-seventh Scientific Meeting of the
International Society for Cardiovascular Surgery, North
American Chapter, Washington, DC, Jun 8–9, 1999.
Reprint requests: Anthony D. Whittemore, MD, Brigham and
Women’s Hospital, 75 Francis St, Boston, MA 02115.
J Vasc Surg 2000;31:1-8.
Copyright © 2000 by The Society for Vascular Surgery and
International Society for Cardiovascular Surgery, North
American Chapter.
0741-5214/2000/$12.00 + 0 24/6/102727
dence for the subspecialty. I use the word potential
advisedly, because I am aware of healthy skepticism on
the part of many here, but the sub-board is a necessary
step in the evolution of our specialty’s governance.
Rest assured, the American Board of Vascular Surgery
remains legally constituted with strategic plans to pro-
ceed if necessary, although at considerable financial
expense and with the loss of aggregate voice. I remain
confident that the sub-board is being given the
authority required to ensure the highest caliber of edu-
cational standards. Certification of the educational
process, however, does not ensure its competent appli-
cation throughout the course of a surgeon’s career.
The application of performance metrics to monitor
competency currently rests with the individual institu-
tion, as I will mention later.
An effective Government Relations Committee,
which ensures we remain informed about actions
here in Washington that may affect health care in
general and, more specifically, vascular surgery, has
been developed. The committee provides a conduit
able to transmit our concerns directly to the Health
Care Financing Administration at the Bethesda cam-
pus and indirectly through the Relative Value Update
Committee, on which we have just secured a seat for
the next 2 years. As of January 1998, reimbursement
for our Medicare beneficiaries was reduced 9% with
the institution of the single conversion factor.
Further changes in reimbursement for the practice
expense component results in an additional 11%
reduction, to be phased in within the next 4 years.2
The net effect, adjusted for inflation, is an approxi-
mately 30% reduction in Medicare reimbursement,
not only for carotid endarterectomy, but also for
repair of aortic aneurysm and lower-extremity bypass
grafting, our three signature arterial procedures.
The Balanced Budget Act of 1997 ensures that
this situation is not likely to improve in the near
future. Of the $115 billion required to balance the
budget, 88% derives from Medicare.3 As a result, pro-
jected operational losses among the Boston teaching
hospitals for the current fiscal year range from $8 to
$120 million. The University of Pennsylvania system
faces a $175 million shortfall, and Stanford-UCSF
must eliminate approximately 2000 positions. These
losses are not sustainable, but will literally require an
act of Congress, a new President, or a more militant
physician organization to remedy. Our small society,
with its membership of 1651, must maintain a strong
alliance with other organizations and surgical special-
ties to ensure that a loud aggregate voice is heard in
Washington. In my opinion, reduction in reimburse-
ment to hospitals and physicians represents a far
greater threat to our patients than any consideration
of who administers an examination or which discipline
manipulates the end of the catheter.
It is all too easy to lose sight of our prime pur-
pose amid the aforementioned political efforts to
assert our independence, accommodate interven-
tionalists from other disciplines, and fight with gov-
ernment for economic survival. Our common goal is
to promote the highest caliber of care for patients
with any variation of vascular disease. I would like to
emphasize a strategy that may provide the team best
suited to achieve that goal.
Bearing in mind my literary heritage, perhaps
you’ll both understand and forgive the metaphor
that struck me as I watched one of our interven-
tionalists insert a 22F introducer into a jugular vein.
Interventionalists of one sort or another have been
around for some time. Let me introduce you to an
earlier iteration, highly skilled in a very pragmatic
application of remote intervention (Fig 1). Meet the
Pequod’s first harpooner, Queequeg who, along
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Fig 1. Illustration by Rockwell Kent from Herman
Melville’s Moby Dick. New York: Random House; 1930.
with Yorpy, ranks among the most intriguing of my
great great grandfather’s characters. During a whal-
ing voyage, on sighting a spout from the masthead,
three or four longboats were lowered away for the
chase. Each longboat was captained by one of the
mates, whose share of the profits from the voyage
was often incentive-based, proportionate to the
number of successful encounters. The harpooner’s
share above ordinary seamen’s wages often depend-
ed on the largess of his mate. The harpooner pulled
first oar forward, appropriately positioned to stand
in the bow and dart his iron some 30 feet astern of
his target. After the strike, he would exchange places
with the mate and assume the boatsteerer’s position,
aft at the steering oar. When the whale tired, the
mate, now forward, placed his irons to claim the kill
and his incentive bonus. Alas, the harpooner could
only admire the mate’s cash balance at the conclu-
sion of the voyage. Until recently, how durable the
metaphor! In most vessels, able seamen lived in the
fo’c’sle. On the old whalers, however, the extraordi-
nary skills of the harpooner were held in such high
regard that they were allowed to berth and take their
meals in the after quarters with the master and his
mates. The harpooner and his mate were the critical
team on which the success of the entire voyage
depended.
Queequeg was, of course, much more than a skill-
ful technician engaged in the chase for the white
whale. He was a native islander from the South Seas
and was extensively tattooed—one horrific apparition
(Fig 2)! Ishmael was none too pleased to learn he had
to share a bed at the Spouter Inn, and you can imag-
ine his reaction on discovering his bedfellow was a
savage. The subsequent development of Queequeg’s
character testifies to Melville’s deep concern about the
inequities of social and racial standing. His wife,
Lizzy, was the daughter of Judge Lemuel Shaw, a
Bostonian with abolitionist leanings. Melville’s social
tolerance was further reinforced by his experience
with the natives inhabiting the Typee Valley in the
Marquesas Islands; their inherent passive nature was
usually misrepresented, and therefore, they were
much feared. Ishmael’s relationship with the har-
pooner, as it evolves throughout Moby Dick, reflects
Melville’s intellectual tolerance. Queequeg embodies
fear of the unfamiliar and all things threatening, but,
contrary to his terrifying appearance and propensity
for mysterious ritual, he proved kind, thoughtful, and
fiercely protective of his mates. He was revered by the
crew, berthed with the officers, and became Ishmael’s
closest shipmate aboard. The ultimate irony occurred
as the Pequod slipped beneath the shrouds of the sea.
Up from the deep shot Queequeg’s coffin, the life
buoy to which Ishmael clung, sparing him from the
final vortex. The harpooner played a vital role in the
early whaling industry, not altogether dissimilar to our
modern interventional counterparts, who, as vital
members of our team, provide a set of skills that may
be perceived either as threatening or complementary
to our own. From strange bedfellows do trusted col-
leagues emerge.
Those of you who know me well understand I
am aware of the attributes of individual performance
in appropriate circumstances. I have been known to
try to shave a few seconds off my best downhill time,
much to the detriment of those sharing my airspace
and in defiance of any shred of common sense! But
other goals are best attained through the efforts of a
team-approach that draws on the individual assets of
each component, assets with which we are not all
equally endowed. The brute force required for the
coffee-grinders below decks contrasts sharply with
the agility of the foredeck crew, yet both must work
together with great precision to cross the finish line
first. Because the whole is indeed often greater than
the sum of its parts, we need the Queequegs, along
with the mates and the master.
Yesterday’s critical issues session and last month’s
meeting in Chicago testify to the increasing interest
in the vascular center, a concept with the potential to
create a collaborative environment by drawing on
the assets of several medical disciplines. In 1992,
Jimmy Yao asked me to present this concept at the
Critical Issues Forum, based on our early efforts at
Brigham to establish this multidisciplinary approach
for our patients with systemic vascular disease. It
proved to our very good fortune that David
Robinson from National Institutes of Health was
also a participant. I would like to review the history
of this concept as it has played out, in hopes that
some suggestions may prove useful in your individ-
ual practice environment.
Seventeen years ago, during the spring of 1982,
I had a conversation with Victor Dzau along the
Pike in the old Peter Bent Brigham, a long corridor,
familiar to many of you, that has spawned a number
of notable ideas, some of which have actually been
good! Our conversation stemmed from my concern
about our continued ability as surgeons to care for
patients with vascular disease, based on the estab-
lished template of an all-encompassing specialty that
provided much of the primary care for patients with
symptomatic atherosclerosis. There were three pri-
mary drivers underlying my concern.
The first and most important driver was our
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aging patient population, the complex comorbidities
of which presented an impressive challenge. An
example of such a patient, and you will all recognize
her, is a 72-year-old woman with type 1 diabetes
mellitus and hypertension managed with Inderal.
She was taking synthroid for reasons that were not
altogether clear. Her significant coronary disease
required isordil and intermittent nitroglycerine for
angina, digoxin and lasix for congestive failure, and
coumadin for her chronic atrial fibrillation. In spite
of her progressive renal failure, she still took stan-
dard potassium supplements for her lasix and inder-
al for her hypertension, all of which were prescribed
by three different physicians. She was given Trental
for her peripheral vascular disease, and her persistent
ischemic ulcer was carefully dressed with a tight
Unna boot. She was given niacin and placed on a
low cholesterol diet for her hyperlipidemia, which,
along with her low protein diet for renal disease and
low carbohydrate diet for diabetes, resulted in con-
siderable confusion about what was left for her to
eat. She had undergone a total hip replacement, and
her degenerative arthritis required chronic non-
steroidals and prednisone. Her resultant gastritis was
treated with Zantac, her anxiety with Xanax, and, lit-
tle wonder, she had trouble sleeping and needed a
touch of Halcion! She thus required 25 individual
doses of 16 medications each day, which were pre-
scribed by 11 subspecialists and her bewildered pri-
mary care physician. One or two office visits each
week presented her with yet another daunting chal-
lenge in trying to arrange transportation, which is
potentially more life-threatening in Boston than the
underlying disease process, as is finding a parking
space. Not infrequently, it proves more cost-effective
to settle for a parking ticket.
The second driver was the rapidly changing field
of cardiology, with its increasingly complex pharma-
cology, including ace inhibitors, calcium channel
blockers, beta-blockers, and sophisticated antiarrhyth-
mics, all with their specific idiosyncrasies and adverse
interactions. Considering the similar progress in the
management of diabetes mellitus, hypertension, and
thromboembolic disorders, I could not see us, as sur-
geons, continuing to provide comprehensive care for
our patients without some help, particularly in an aca-
demic environment with its inherent commitment to
teaching and productivity in basic science. Catheter-
based technology was developing rapidly, and it was
clear that cardiologists would become preoccupied
with the myocardium and adopt a progressively
myopic view of systemic atherosclerosis. We needed a
new subspecialty of medicine to provide care that
included all manifestations of the underlying disease
and more effective risk reduction. We managed to
convince physician-in-chief Eugene Braunwald to cre-
ate a Division of Vascular Medicine for our embryon-
ic Vascular Center.
The third driver was the proven viability of per-
cutaneous transluminal angioplasty, an approach
that would gain wider acceptance with rapidly devel-
oping catheter technology. Because our angiogra-
phers were far more skilled with the business end of
intravascular catheters and we had our hands full
with our own surgical caseload, we welcomed their
appropriate application of this emerging technology.
Rather than diluting our surgical experience, endo-
luminal technology actually enhanced both surgical
and interventional volume.
Our primary goal in initiating the center concept
was to provide expeditious, but comprehensive,
multidisciplinary care for our vascular patients. Yet
there were obvious second derivatives for the educa-
tional and research missions of an academic institu-
tion. We were reasonably effective at educating our-
selves about the benefits of vascular reconstruction,
but the message was not getting to the referring pri-
mary care physicians. For instance, a patient with
repetitive transient ischemic attacks and a 95%
carotid stenosis was observed with great diligence
for 5 months before referral. Severely ischemic toes
were carefully observed for the better part of a year
and progressed to dry gangrene long before we were
asked to consider reconstruction. An abdominal aor-
tic aneurysm was allowed to mature to a full eight
centimeters with semiannual ultrasounds. A 67-year-
old woman was admitted to the medical service of
one of our finest hospitals in Boston with lower back
pain and a low-grade fever. A retroperitoneal mass,
which instantly prompted the diagnosis of lym-
phoma and a directed needle biopsy, was revealed by
means of a computed tomography scan. The histo-
logic examination proved compatible with old
blood, a finding that so befuddled the attending
physicians that they repeated the biopsy. The results
proved similar, and, because her pain had subsided,
she was declared stable and discharged. Two weeks
later, of course, she returned for repair of her rup-
tured mycotic aneurysm. We have an ongoing need
to educate our non-surgeon colleagues, and what
better way than to provide multidisciplinary educa-
tion during our training programs and to our refer-
ring physicians through a written longitudinal care
plan at discharge?
For research in vascular disease, it was becoming
increasingly difficult for a clinically dedicated surgeon
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to maintain both a productive laboratory and the
level of clinical skill required for a volume-dependent
specialty. Study sections required higher proportions
of time committed to the laboratory to successfully
compete for the shrinking research dollar. Industrial
sponsors demanded short-term return on investment
for the benefit of their stockholders, precluding
longer-range projects. Compliance with a variety of
regulatory agencies and animal rights activists, espe-
cially in Massachusetts, proved time consuming. I
came in one morning to find a plastic garbage bag
containing two dead dogs outside my laboratory
door, and on another occasion, the keyhole for the
lock was irrevocably injected with epoxy. It was
increasingly difficult for all except established investi-
gators to develop the infrastructure necessary to
maintain funding, compliance, and equipment for
innovative research. There seemed great virtue in the
concept of a multidisciplinary core facility, main-
tained by full-time, scientifically credible basic inves-
tigators, that could incorporate the more clinically
inclined in both basic and translational investigations.
As we were developing our vascular center, it was
clear we needed institutional support for both space
and personnel. David Robinson at the National
Heart, Lung, and Blood Institute and the members
of our Society were able to secure funding for 15
academic awards of $5 million each for 5 years,
designed to promote the interdisciplinary concept.
The first awards were given to Mark Creager at our
center and John Cook, who had headed west with
Victor Dzau to Stanford. These awards required
institutional support and, therefore, provided great
impetus to develop an organizational infrastructure
and to allocate appropriate space. The award also
facilitated creation of fellowships in vascular medi-
cine and the Society for Vascular Medicine and
Biology.
The organizational structure of our multidiscipli-
nary center is hospital based (Fig 3). The division
chiefs work together as the operational team, and
although I was the initial director, we have rotated the
position among the disciplines to allow routine deci-
sions to be made expeditiously by a single person.
However, because all three division chiefs are co-direc-
tors, major decisions represent either consensus or
compromise, and all continue to report to the chair of
their respective academic departments. Operational
decisions about patient care, critical pathways, and
quality assurance are made jointly, and their imple-
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Fig 2. Illustration by Rockwell Kent from Herman
Melville’s Moby Dick. New York: Random House; 1930.
Fig 3. Organizational chart for the Vascular Center at the
Brigham and Women’s Hospital.
mentation is facilitated by a service line administrator.
Our nurse practitioner, a critical member of the clini-
cal team, facilitates communication with referring
physicians, patient admission, and the subsequent
transition to home or subacute facility. Our scheduling
coordinator must juggle individual surgeons’ sched-
ules with bed availability, the operating room schedule,
and the patient’s family obligations, while ensuring
proper authorization from the third-party payer.
The major objective of the center is to provide
optimal care with maximal efficiency. Patients are
referred primarily to the vascular internist or sur-
geon and, on occasion, directly to the intervention-
alist. We make every effort to have the patient seen
by both internist and surgeon or radiologist during
the first visit. If an intervention is indicated for the
specific clinical problem, our coordinator selects a
date, and the patient is sent for routine laboratory
work. Aside from duplex scanning, most elective
imaging studies must be scheduled in advance and
therefore require a second trip, coordinated with any
further cardiac evaluation necessary. Every attempt is
made to streamline the process to avoid repeat visits,
so the patient next returns at first light on the morn-
ing of the surgical or endovascular procedure.
During admission, patients are observed both by
members of the vascular medicine and either surgery
or radiology departments until discharge. Our inter-
ventional radiology service admits its patients for
overnight observation after routine interventions, a
privilege that has greatly relieved our overburdened
surgical staff of considerable paperwork. The vascu-
lar internist generates a comprehensive longitudinal
care plan that incorporates the preoperative evalua-
tion, hospital course, and recommendations for
management of the various comorbidities. This
report is sent to referring and primary care physi-
cians when the patient is discharged. Our fear that
this effort would be perceived as meddlesome has
not been borne out, because most of our referring
physicians are appreciative of the educational oppor-
tunity, which is reflected in part by the growth of
our volume.
In an effort to determine whether we were pro-
viding efficient, high-caliber care, we established the
usual metrics to track activity and outcomes that are
reviewed at our monthly conference. During the last
3 years, the number of visits to the vascular medical
clinic has steadily increased. The number of interven-
tions in the angiography suite is followed, along with
outcome parameters, in our registry. There has been a
logarithmic 65% increase in endovascular interven-
tions, which now number more than 800. Finally, the
surgical volume has paralleled the upward trend, with
a 29% increase, or currently 1100 procedures. So
much for volume, how about quality?
We have published our overall short-term results,
which document a 1.6% 30-day operative mortality
for all surgical reconstructions, but that is only one
point in time and does not provide ongoing surveil-
lance of individual competence. We developed a set
of performance metrics for our three most common
primary surgical procedures, because they are rea-
sonably standardized and allow comparison among
surgeons. After all, the earned run average, or ERA,
of every pitcher in major league baseball is available
in the newspaper everyday. What’s more important,
baseball or the brain? Shouldn’t a surgeons’ earned
stroke average, or ESA, be available as well? We
therefore track individual surgeons’ operative mor-
bidity, average patient length of stay, and operating
time to allow constructive quality assurance (Fig 4).
Cost per intervention cannot be far away! The
process could remain anonymous to everyone except
the division chief, but in our center, all laundry is
labeled, which ensures that all interventions, irre-
spective of discipline, are held to uniform standards.
Critical to our academic mission, all three divi-
sions participate in clinical or translational research
projects, which currently include trials to evaluate
atorvastatin and protein kinase C inhibition for clau-
dication and the effect of estradiol on vasoreactivity.
Clinical studies of the influence of platelet aggrega-
tion and the efficacy of hirudin on vein graft patency
are ongoing, as are aortic endograft trials and evalua-
tion of a peripheral stent-graft. Sources of variability
in Doppler-derived estimates of carotid stenosis are
being actively pursued in our noninvasive laboratory.
In addition, we are between the first and second phas-
es of a human gene transfection protocol with a decoy
transcription factor designed to minimize smooth
muscle hyperplasia in vein grafts. Critical members of
this translational team include our clinical research
nurse, who oversees our contracts, facilitates institu-
tional review board approval, and maintains compli-
ance with the industry’s clinical monitors, the Food
and Drug Administration and the Health Care
Financing Administration. A second vital member of
the team maintains our clinical vascular registry.
The Division of Vascular Medicine provides over-
sight for basic science research and maintains the core
infrastructure for the center. The vascular internists
concentrate on endothelial dysfunction in diabetes
mellitus, aspects of thromboembolic disease, and arte-
rial dysfunction in the context of atherogenesis and
intimal hyperplasia. Mike Conte in our surgical divi-
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sion is applying gene transfer strategies to improve the
outcomes of vascular procedures. Present funding
derives from a SCOR grant, two Program Projects, an
R37, seven RO1s, and a KO8. An established investi-
gator award from the American Heart Association
and 10 industry-sponsored awards keep us all very
busy in research activities.
Several objectives have not yet been met, includ-
ing combined daily work rounds with the attending
staff. We hold our multidisciplinary teaching confer-
ence on a regular weekly basis, but because of sig-
nificant differences in circadian rhythm between sur-
geons and internists, we have been unable to sustain
daily rounds at the attending level. The fellows and
residents, however, are in constant communication
throughout the day, so there is no lack of inter-
change among the disciplines. Our vascular fellows
have a structured hands-on rotation in the angiogra-
phy suite, and reciprocity is extended to our inter-
ventionalists, so that endovascular procedures in the
operating room are a team effort.
A second clinical goal that has proven elusive is a
successful risk-reduction program. We have tried
several approaches to smoking cessation and weight
control, all of which have failed, primarily because of
a notable lack of enthusiasm on the part of our
patients. We continue to provide motivation and
opportunity, but seem unable to overcome the
determined inertia of the hardcore soul-at-risk!
Finally, we have not achieved multidisciplinary eco-
nomic integration, nor has it been aggressively sought,
because it is not crucial when all components are
working at capacity. Assuming there is an economy left
to integrate, there are several alternatives that eliminate
competition for patients among disciplines and pro-
vide economic stability while adapting to emerging
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Fig 4. Outcome metrics for primary signature procedures by individual surgeons within the
Division of Vascular Surgery at the Brigham and Women’s Hospital.
technology. Works-in-progress are ongoing and
include New York University, Washington University,
and the University of Rochester, among others. A cen-
ter may adopt the senior partner model, in which exist-
ing members are automatically vested and revenue is
distributed equally among them. Junior recruits might
receive an initial salary before becoming vested as a
senior partner. Alternatively, the salary guidelines of
the Association of American Medical Colleges or his-
toric local salaries may be used as references for estab-
lishing relative equity, with funds ultimately distrib-
uted proportionate to the historic contributions from
each discipline. The Association of American Medical
Colleges’ average salaries for academic rank according
to specialty can be used to determine the aggregate
professional revenue anticipated for a specific compo-
nent of the center. For instance, in the case of our
Division of Vascular Surgery, with a full professor as
chief, two associate professors, and an assistant profes-
sor, the aggregate academic average may be ascer-
tained. When combined with similar figures calculated
for the other two divisions, relative proportions of the
total may be determined. Based on this method, 
our Division of Vascular Surgery accounts for 42%,
Vascular Medicine for 26%, and Interventional
Radiology for 32% of the total income pool. If salary
support derived from research grants is excluded and
relative contributions determined solely on the basis of
clinical income, the proportions change accordingly.
Going forward, professional funds may be distributed
to each division according to these proportions, irre-
spective of the total. Each division chief, after con-
tributing to the welfare of the dean and department
chair, may then distribute the funds equally or accord-
ing to rank or seniority. Competition is therefore min-
imized, as are the effects of changing technology on
individual disciplines with time.
Little did we know that the economic constraints
of the late 1990s, resulting from the Balanced Budget
Act of 1997, would wreak such havoc on our health
care system. Hospitals of all descriptions and individ-
ual clinicians must use every trace of ingenuity to
achieve financial stability. A well-coordinated, cost-
effective multidisciplinary team is required to maintain
the extraordinary caliber of medical care that our
patients have come to expect and deserve. As conven-
tional departmental infrastructure becomes dysfunc-
tional, the new working relationships that translate
into best practice cannot be imposed either by execu-
tive or committee, but must be worked out through
trial and error at the ground level in one’s own 
environment with time. Rather than prey on vulnera-
bilities, we need to build on each other’s assets, irre-
spective of clinical discipline, especially during these
economically challenging times. From the strangest of
bedfellows do the most important ingredients emerge:
the basic trust and mutual respect that underlie an
effective multidisciplinary, disease-focused approach to
vascular disease.
I thank you all for the singular honor to have
served as your officer and president. It has been the
effort of an extraordinary team, the most important
members of which are my best friends in the front
row. We are truly grateful for so many of you who
have responded to our need and applied the variety
of your talents for the benefit of our specialty and,
therefore, our patients.
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